RAAS Inhibitor Prescription and Hyperkalemia Event in Patients With Chronic Kidney Disease: A Single-Center Retrospective Study.

MLA

Riccio, Eleonora, et al. “RAAS Inhibitor Prescription and Hyperkalemia Event in Patients With Chronic Kidney Disease: A Single-Center Retrospective Study.” Frontiers in Cardiovascular Medicine, vol. 9, Feb. 2022, p. 824095. EBSCOhost, https://doi.org/10.3389/fcvm.2022.824095.

APA

Riccio, E., Capuano, I., Buonanno, P., Andreucci, M., Provenzano, M., Amicone, M., Rizzo, M., & Pisani, A. (2022). RAAS Inhibitor Prescription and Hyperkalemia Event in Patients With Chronic Kidney Disease: A Single-Center Retrospective Study. Frontiers in Cardiovascular Medicine, 9, 824095. https://doi.org/10.3389/fcvm.2022.824095

Chicago

Riccio, Eleonora, Ivana Capuano, Pasquale Buonanno, Michele Andreucci, Michele Provenzano, Maria Amicone, Manuela Rizzo, and Antonio Pisani. 2022. “RAAS Inhibitor Prescription and Hyperkalemia Event in Patients With Chronic Kidney Disease: A Single-Center Retrospective Study.” Frontiers in Cardiovascular Medicine 9 (February): 824095. doi:10.3389/fcvm.2022.824095.